Saizen and Memory loss - a phase IV clinical study of FDA data

Summary:

Memory loss is reported as a side effect among people who take Saizen (somatropin recombinant), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Melatonin, and have Growth hormone deficiency.

The phase IV clinical study analyzes which people have Memory loss when taking Saizen. It is created by eHealthMe based on reports of 3,115 people who have side effects when taking Saizen from the FDA, and is updated regularly.

What is Saizen?

Saizen has active ingredients of somatropin recombinant. eHealthMe is studying from 3,122 Saizen users. Check the latest studies of Saizen.

What is Memory loss?

Memory loss is found to be associated with 2,726 drugs and 4,378 conditions by eHealthMe. Check the latest studies of Memory loss.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

3,115 people reported to have side effects when taking Saizen.
Among them, 15 people (0.48%) have Memory loss.

Among these 15 people:

How long have people been on Saizen when they have Memory loss? *

What is the gender of people who have Memory loss when taking Saizen? *

female: 60 %
male: 40 %

What is the age of people who have Memory loss when taking Saizen? *

What are other drugs people take besides Saizen? *

What are other side effects people have besides Memory loss? *

Nausea And Vomiting: 4 people, 26.67%
Headache (pain in head): 3 people, 20.00%
Arrhythmias (irregular heartbeat): 3 people, 20.00%
Fatigue (feeling of tiredness): 3 people, 20.00%
Blood Pressure Abnormal: 3 people, 20.00%
Weight Increased: 2 people, 13.33%
Muscle Spasms (muscle contraction): 2 people, 13.33%
Mental Impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition): 2 people, 13.33%
Malaise (a feeling of general discomfort or uneasiness): 2 people, 13.33%
Dry Skin: 2 people, 13.33%

What are the existing conditions these people have? *

Growth Hormone Deficiency: 7 people, 46.67%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 13.33%
Body Height Below Normal: 2 people, 13.33%
Thyroid Diseases: 1 person, 6.67%
Menopause (end of monthly cycles in women): 1 person, 6.67%
Hypothalamo-Pituitary Disorders (loss of function in an endocrine gland due to failure of the pituitary gland to secrete hormones which stimulate that gland's function): 1 person, 6.67%
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 1 person, 6.67%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 6.67%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 6.67%
Adrenal Insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Saizen and have Memory loss?

- Check whether Memory loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Saizen:

Saizen (3,122 reports)

Memory loss treatments and more:

Memory loss (244,445 reports)

Browse all side effects of Saizen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Memory loss:

Memory loss (2,726 drugs)

Browse all the conditions that are associated with Memory loss:

Memory loss (4,378 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on somatropin recombinant (the active ingredients of Saizen) and Saizen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.